Angion Biomedica is a biotechnology business based in the US. Angion Biomedica shares (ANGN) are listed on the NASDAQ and all prices are listed in US Dollars. Angion Biomedica employs 71 staff and has a trailing 12-month revenue of around $28.2 million.
How to buy Angion Biomedica stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ANGN. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Angion Biomedica stock price (NASDAQ: ANGN)
Use our graph to track the performance of ANGN stocks over time.Angion Biomedica shares at a glance
Latest market close | $0.70 |
---|---|
52-week range | $0.59 - $2.94 |
50-day moving average | $0.84 |
200-day moving average | $1.13 |
Wall St. target price | $1.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.08 |
Buy Angion Biomedica stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Angion Biomedica stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Angion Biomedica price performance over time
Historical closes compared with the close of $0.7 from 2023-02-01
1 week (2023-01-26) | 0.7 |
---|---|
1 month (2022-12-30) | -13.75% |
3 months (2022-11-02) | -27.80% |
6 months (2022-08-02) | -33.96% |
1 year (2022-02-02) | -74.64% |
---|---|
2 years (2021-01-29) | N/A |
3 years (2020-01-29) | N/A |
5 years (2018-01-29) | N/A |
Angion Biomedica financials
Revenue TTM | $28.2 million |
---|---|
Gross profit TTM | $-20,819,000 |
Return on assets TTM | -8.68% |
Return on equity TTM | -30.47% |
Profit margin | -61.88% |
Book value | $1.67 |
Market capitalisation | $21.1 million |
TTM: trailing 12 months
Angion Biomedica share dividends
We're not expecting Angion Biomedica to pay a dividend over the next 12 months.
Angion Biomedica overview
Angion Biomedica Corp. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York. .
Angion Biomedica in the news
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – KNBE, PSBP, ANGN, TIG
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, CNCE, AQUA
Moore Kuehn Encourages KERN, CNCE, AQUA and ANGN Investors to Contact Law Firm
Frequently asked questions
What percentage of Angion Biomedica is owned by insiders or institutions?Currently 32.777% of Angion Biomedica shares are held by insiders and 17.001% by institutions. How many people work for Angion Biomedica?
Latest data suggests 71 work at Angion Biomedica. When does the fiscal year end for Angion Biomedica?
Angion Biomedica's fiscal year ends in December. Where is Angion Biomedica based?
Angion Biomedica's address is: 51 Charles Lindbergh Boulevard, Uniondale, NY, United States, 11553 What is Angion Biomedica's ISIN number?
Angion Biomedica's international securities identification number is: US03476J1079
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert